Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 340121 - 340140 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Namibia | (L01FD01) trastuzumab | HERCEPTIN 440MG FOR IV SOLN | 1x | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | n/a |
| Namibia | (L01FG01) bevacizumab | ABEVMY 100MG/4ML CONC FOR SOLN | 1x | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Namibia | (L01FG01) bevacizumab | ABEVMY 400MG/16ML CONC FOR SOLN | 1x | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | n/a |
| Namibia | (L01FG01) bevacizumab | AVASTIN 100MG/4ML INF | 1x | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | n/a |
| Namibia | (L01FG01) bevacizumab | AVASTIN 400MG/16ML INF | 1x | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | n/a |
| Namibia | (L01XG01) bortezomib | VELCADE 1MG VIAL POWD FOR RECO | 1x | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
| Namibia | (L01XG01) bortezomib | VELCADE 3.5MG POWD FOR RECON | 1x | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | n/a |
| Namibia | (L02BA03) fulvestrant (adm: P) | FASLODEX 250MG/5ML INJ PREFILL | 2x | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
| Namibia | (L02BA03) fulvestrant (adm: P) | FULVESTRANT MYLAN 250MG/5ML PREFILL SYRINGE INJ | 2x | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
| Namibia | (L02BB04) enzalutamide (adm: O) | XTANDI 40MG CAPS | 112x | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | n/a |
| Namibia | (L02BX03) abiraterone (adm: O) | ZYTIGA 250MG TABS | 120x | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | n/a |
| Namibia | (L02BX03) abiraterone (adm: O) | ZYTIGA 500MG TABS | 60x | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | n/a |
| Namibia | (L03AA02) filgrastim (adm: P) | ZARZIO 30 MU 300MCG/0.5ML PREFILLED SYRINGE | 1x | Retail price without vat |
$0-0 |
$0-0 |
Hematopoietic Stem Cell Transplantation;Cancer | n/a |
| Namibia | (L03AA02) filgrastim (adm: P) | ZARZIO 30 MU 300MCG/0.5ML PREFILLED SYRINGE | 5x | Retail price without vat |
$0-0 |
$0-0 |
Hematopoietic Stem Cell Transplantation;Cancer | n/a |
| Namibia | (L03AA02) filgrastim (adm: P) | ZARZIO 48 MU 480MCG/0.5ML PREFILLED SYRINGE | 5x | Retail price without vat |
$0-0 |
$0-0 |
Hematopoietic Stem Cell Transplantation;Cancer | n/a |
| Namibia | (L03AA13) pegfilgrastim (adm: P) | FULPHILA 6MG/0.6ML PREFILLED SYRINGE | 1x | Retail price without vat |
$0-0 |
$0-0 |
n/a | n/a |
| Namibia | (L03AA13) pegfilgrastim (adm: P) | ZIEXTENZO 6MG/0.6ML PREFILLED SYRINGE | 1x | Retail price without vat |
$0-0 |
$0-0 |
n/a | n/a |
| Namibia | (L03AX16) plerixafor (adm: P) | MOZOBIL 20MG/1ML 1.2ML | 1x | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma;Hematopoietic Stem Cell Transplantation;Lymphoma | n/a |
| Namibia | (L04AA06) mycophenolic acid | CELLCEPT 250MG CAPS | 100x | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | n/a |
| Namibia | (L04AA06) mycophenolic acid | CELLCEPT 500MG TABS | 50x | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection | n/a |
Pages
